Stockreport

Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF - 2025 net product sales of approximately $520 million (preliminary and unaudited) exceed upper end of guidance- 2026 expected global net product sales of $630 million t [Read more]